pharmaphorum

JUNE 8, 2021

The entire APAC region already accounts for 30% of all global pharma spending, and within these markets national healthcare expenditure is expected to increase threefold to over $2 trillion by 2030. Chemotherapy still accounted for 72.6% million in 2030. of the oncology market in China in 2019, compared to 17.1%

Chemotherapy 105

Chemotherapy Pharmaceutical Companies Pharmaceutical Companies Immunization 105

Roots Analysis

OCTOBER 4, 2023

They are designed to recognize and bind to two specific molecules, such as a tumor cell and an immune cell, or two different parts of the same molecule. Bispecific antibodies are a type of antibody that can bind to two different targets at the same time. during the period 2023-2035.

Chemotherapy 40

Chemotherapy Immunization FDA 40

The Checkup by Singlecare

AUGUST 3, 2023

The costs are expected to increase to $246 billion by the year 2030. billion in out-of-pocket expenses for their surgery, radiation, and chemotherapy. These are the most common types of cancer treatment : Chemotherapy: Many people get treated with chemotherapy drugs that kill or shrink cancer cells. in 2023. (

Chemotherapy 98

Chemotherapy Hospitals Insurance Immunization 98